Johannes G Bode Selected Research

Johannes G Bode Research Topics

Disease

6	Infections 01/2023 - 10/2004
5	Acute-Phase Reaction 01/2017 - 11/2006
4	Inflammation (Inflammations) 11/2023 - 04/2010
2	Sepsis (Septicemia) 12/2021 - 01/2021
2	Hemorrhage 12/2021 - 06/2015
2	COVID-19 05/2021 - 05/2021
2	Liver Diseases (Liver Disease) 01/2021 - 04/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 06/2015
2	Virus Diseases (Viral Diseases) 01/2016 - 11/2008
2	Brain Diseases (Brain Disorder) 04/2015 - 12/2009
2	Hepatocellular Carcinoma (Hepatoma) 10/2010 - 10/2005
2	Persistent Infection 10/2008 - 06/2007
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Portal Hypertension 12/2021
1	Liver Failure 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Neglected Diseases 12/2021
1	Schistosomiasis (Bilharziasis) 12/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021
1	Body Weight (Weight, Body) 05/2021
1	Diabetes Mellitus 05/2021
1	Hypersensitivity (Allergy) 05/2021
1	Neoplasms (Cancer) 05/2021
1	Pancreatitis 05/2021
1	Pneumonia (Pneumonitis) 05/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2021
1	IgA Deficiency 05/2021
1	Disease Progression 05/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2021
1	Chronic Renal Insufficiency 05/2021
1	Transfusion Reaction 05/2021
1	Sclerosing Cholangitis 05/2021
1	Cysts 01/2021
1	Bacteremia 01/2021
1	Necrosis 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Hyperammonemia 04/2015
1	End Stage Liver Disease 04/2015
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2012
1	Chronic Hepatitis C 10/2010
1	Hepatic Encephalopathy 12/2009
1	Cholestasis 11/2006
1	HIV Infections (HIV Infection) 07/2006

Drug/Important Bio-Agent (IBA)

4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2004
3	Antiviral Agents (Antivirals)IBA 01/2018 - 06/2007
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2010
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2017 - 06/2012
2	Interferon Type IIBA 01/2016 - 11/2008
2	Bile Acids and Salts (Bile Acids)IBA 10/2010 - 11/2006
2	CytokinesIBA 04/2010 - 03/2010
1	AlarminsIBA 11/2023
1	sotrovimabIBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	camostatIBA 05/2021
1	AntibodiesIBA 05/2021
1	Capsules (Microcapsules)IBA 05/2021
1	Oxygen (Dioxygen)IBA 05/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	LigandsIBA 01/2018
1	CollagenIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Activins (Activin)IBA 01/2017
1	Growth Differentiation Factor 2IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 04/2015
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 04/2015
1	Urea (Carbamide)FDA LinkGeneric 04/2015
1	AmmoniaIBA 04/2015
1	Complement System Proteins (Complement)IBA 06/2012
1	IronIBA 06/2012
1	GlucocorticoidsIBA 01/2012
1	InterferonsIBA 10/2010
1	eIF-2 Kinase (eIF 2 Kinase)IBA 10/2010
1	Taurocholic Acid (Sodium Taurocholate)IBA 10/2010
1	Staphylococcal Protein A (Protein A)IBA 10/2010
1	Peptides (Polypeptides)IBA 10/2010
1	Messenger RNA (mRNA)IBA 10/2010
1	Interleukin-17 (Interleukin 17)IBA 04/2010
1	ChemokinesIBA 04/2010
1	Viral Nonstructural ProteinsIBA 04/2007
1	Interferon-betaIBA 04/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2007
1	Fibrinogen (Factor I)FDA Link 10/2005

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2006
3	Transjugular Intrahepatic Portasystemic Shunt 12/2021 - 12/2009
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2021 - 12/2009
1	Organ Transplantation 01/2023
1	Catheters 12/2021
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 12/2021
1	Conservative Treatment 12/2021
1	Cannula 05/2021
1	Contraindications 05/2021
1	Aftercare (After-Treatment) 05/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 07/2006